Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of BCR-ABL Tyrosine Kinase Inhibitors (Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity)

Press/Media

Period	17 Jul 2023

Media coverage

Title	Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of BCR-ABL Tyrosine Kinase Inhibitors (Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity)
Media name/outlet	Proteomics Daily
Country/Territory	United States
Date	17/07/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68R2-NPF1-DY7R-R26H-00000-00
Persons	Kinsuk Chauhan, Bridget Marcellino, Kristin Meliambro, Steven Coca, Lili Chan, Evren Azeloglu, Marina Kremyanskaya, John Mascarenhas